Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Menzel

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Communications Biology|July 29, 2025
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancerEva Romanovsky, Michael Menzel, Klaus Kluck, et al.
Pathologie (Heidelberg, Germany)|June 2, 2026
[Artificial intelligence in molecular pathology : Introduction and overview]Daniel Kazdal, Jan Budczies, Michael Menzel, et al.
Studies in Health Technology and Informatics|September 3, 2025
Whole Exome Sequencing on FHIR: Towards Adoption in Clinical Practice for Precision Oncology PipelinesSara Nuhic, Patrick Werner, Daniel Kazdal, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2006
The solid-state architecture of a metallosupramolecular polyelectrolyteUte Kolb, Karsten Büscher, Christiane A Helm, et al.
Cell Death Discovery|April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysisEva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Translational Oncology|June 16, 2023
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)Michael Menzel, Volker Endris, Constantin Schwab, et al.
Nature Reviews. Clinical Oncology|August 27, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvementsJan Budczies, Daniel Kazdal, Michael Menzel, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2024
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in TumorMarkus Ball, Iordanis Ourailidis, Klaus Kluck, et al.
The Journal of Pathology. Clinical Research|January 29, 2024
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitorsMichael Menzel, Martina Kirchner, Klaus Kluck, et al.
British Journal of Cancer|April 7, 2026
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costingChristian Altbürger, Michael Menzel, Susanne Beck, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Communications Biology|July 29, 2025
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancerEva Romanovsky, Michael Menzel, Klaus Kluck, et al.
Pathologie (Heidelberg, Germany)|June 2, 2026
[Artificial intelligence in molecular pathology : Introduction and overview]Daniel Kazdal, Jan Budczies, Michael Menzel, et al.
Studies in Health Technology and Informatics|September 3, 2025
Whole Exome Sequencing on FHIR: Towards Adoption in Clinical Practice for Precision Oncology PipelinesSara Nuhic, Patrick Werner, Daniel Kazdal, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2006
The solid-state architecture of a metallosupramolecular polyelectrolyteUte Kolb, Karsten Büscher, Christiane A Helm, et al.
Cell Death Discovery|April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysisEva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Translational Oncology|June 16, 2023
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)Michael Menzel, Volker Endris, Constantin Schwab, et al.
Nature Reviews. Clinical Oncology|August 27, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvementsJan Budczies, Daniel Kazdal, Michael Menzel, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2024
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in TumorMarkus Ball, Iordanis Ourailidis, Klaus Kluck, et al.
The Journal of Pathology. Clinical Research|January 29, 2024
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitorsMichael Menzel, Martina Kirchner, Klaus Kluck, et al.
British Journal of Cancer|April 7, 2026
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costingChristian Altbürger, Michael Menzel, Susanne Beck, et al.
Pageof 3